Barclays
PMI

Barclays’s Picard Medical PMI Stock Holding History

Barclays’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208 Sell
25
-17
-40% -$361 ﹤0.01% 5106
2026
Q1 		$2.17K Sell
42
-119
-74% -$8.63K ﹤0.01% 4843
2025
Q4 		$14.1K Buy
161
+74
+85% +$17.4K ﹤0.01% 4906
2025
Q3 		$37K Buy
+87
New +$30.6K ﹤0.01% 4839

Other funds holding PMI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Barclays's PMI Position: Q2 2026 in Review

Barclays reduced its Picard Medical (PMI) stake by 40% in Q2 2026, selling an estimated $361 and leaving 25 shares worth $208. The position accounts for ﹤0.01% of the portfolio, ranked #5106.

Barclays first reported a position in PMI in Q3 2025 and has held it in 4 quarters since. The position peaked at $37K in Q3 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Barclays held 25 shares of Picard Medical worth $208 as of Q2 2026.
  • Barclays sold 17 Picard Medical shares in Q2 2026, an estimated $361.
  • Picard Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5106 holding.
  • Barclays first reported a position in Picard Medical in Q3 2025 and has held it in 4 quarters since.
  • Barclays's Picard Medical position peaked at $37K in Q3 2025.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.